Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Worthmann

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Frontiers in Neurology|July 16, 2025
Is helicopter transferal in the "drip-and-ship" approach for endovascular treatment the better choice? A retrospective analysis of transfer timesEvgeniia Lagno, Johanna Ernst, Andreas Flemming, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-FosAxel Lorentz, Mikosch Wilke, Gernot Sellge, et al.
International Journal of Molecular Sciences|February 28, 2013
Asymmetric dimethyarginine as marker and mediator in ischemic strokeShufen Chen, Na Li, Milani Deb-Chatterji, et al.
Journal of Hepatology|December 7, 2013
Active at night, sleepy all day--sleep disturbances in patients with hepatitis C virus infectionMeike Heeren, Faina Sojref, Ramona Schuppner, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 21, 2017
Circulating Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 predict Three-months Outcome after Ischemic StrokeMoritz Armbrust, Hans Worthmann, Reinhard Dengler, et al.
Journal of Neuroinflammation|January 24, 2015
Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infectionHans Worthmann, Anita B Tryc, Meike Dirks, et al.
Frontiers in Neurology|June 24, 2021
Endovascular Treatment of Acute Ischemic Stroke in Clinical Practice: Analysis of Workflow and Outcome in a Tertiary Care CenterKarin Weissenborn, Sam Gruber, Gerrit M Grosse, et al.
Journal of Neuroinflammation|April 12, 2014
The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcomeGerrit M Grosse, Anita B Tryc, Meike Dirks, et al.
Expert Review of Neurotherapeutics|August 6, 2014
Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhageHans-Christoph Diener, Sophia Stanford, Azmil Abdul-Rahim, et al.
Brain : a Journal of Neurology|February 14, 2013
Blood-cerebrospinal fluid barrier dysfunction in patients with neurological symptoms during the 2011 Northern German E. coli serotype O104:H4 outbreakThomas Skripuletz, Ulrich Wurster, Hans Worthmann, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Neurology|July 16, 2025
Is helicopter transferal in the "drip-and-ship" approach for endovascular treatment the better choice? A retrospective analysis of transfer timesEvgeniia Lagno, Johanna Ernst, Andreas Flemming, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-FosAxel Lorentz, Mikosch Wilke, Gernot Sellge, et al.
International Journal of Molecular Sciences|February 28, 2013
Asymmetric dimethyarginine as marker and mediator in ischemic strokeShufen Chen, Na Li, Milani Deb-Chatterji, et al.
Journal of Hepatology|December 7, 2013
Active at night, sleepy all day--sleep disturbances in patients with hepatitis C virus infectionMeike Heeren, Faina Sojref, Ramona Schuppner, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 21, 2017
Circulating Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 predict Three-months Outcome after Ischemic StrokeMoritz Armbrust, Hans Worthmann, Reinhard Dengler, et al.
Journal of Neuroinflammation|January 24, 2015
Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infectionHans Worthmann, Anita B Tryc, Meike Dirks, et al.
Frontiers in Neurology|June 24, 2021
Endovascular Treatment of Acute Ischemic Stroke in Clinical Practice: Analysis of Workflow and Outcome in a Tertiary Care CenterKarin Weissenborn, Sam Gruber, Gerrit M Grosse, et al.
Journal of Neuroinflammation|April 12, 2014
The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcomeGerrit M Grosse, Anita B Tryc, Meike Dirks, et al.
Expert Review of Neurotherapeutics|August 6, 2014
Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhageHans-Christoph Diener, Sophia Stanford, Azmil Abdul-Rahim, et al.
Brain : a Journal of Neurology|February 14, 2013
Blood-cerebrospinal fluid barrier dysfunction in patients with neurological symptoms during the 2011 Northern German E. coli serotype O104:H4 outbreakThomas Skripuletz, Ulrich Wurster, Hans Worthmann, et al.
Pageof 8